GlobeNewsWire
17 Sept 2026, 18:45 UTC · 1h ago
Verdict
Headline leans bearish. We score CLLS −0.80 across two claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−0.80strongly bearish
What the story claims
2 claims · scored −1 bearish … +1 bullish · 1 new · 1 priced in
Cellectis announced on September 14, 2026, that it will exit the development of lasme-cel and eti-cel.
Priced inannounced on September 14, 2026
So whatThe abandonment of two pipeline assets reduces the company's long-term valuation multiples and future revenue potential.
More negative than 98% of claims this week
Law firm Holzer & Holzer, LLC announced on September 17, 2026, an investigation into whether Cellectis complied with federal securities laws.
Continue reading
5 related stories
More negative than 88% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Newpress release dated Sept. 17, 2026
More negative than 73% of claims this week
Which stocks this story touches
More negative than 88% of ticker scores this week
The company is facing a legal investigation following the decision to exit development of key product candidates and a subsequent stock price drop.
More negative than 88% of ticker scores this week
The company is the subject of an investigation by a law firm into whether it complied with federal securities laws.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
4h ago
+6.2%
Price is moving against the score
$1.47 vs $1.38 close before publication (Sep 16) · not market-adjusted
CLLS chart →
